日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Comparison of Trifluridine-Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer

真实世界中三氟尿苷-替吡嘧啶联合或不联合贝伐珠单抗治疗难治性转移性结直肠癌患者的疗效比较

Kim, Hyunho; Shin, Kabsoo; An, Ho Jung; Kim, In-Ho; Bae, Jung Hoon; Lee, Yoon Suk; Lee, In Kyu; Lee, MyungAh; Park, Se Jun

Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)

2024年韩国胃癌诊疗指南:循证多学科诊疗模式(2022年指南更新版)

Kim, In-Ho; Kang, Seung Joo; Choi, Wonyoung; Seo, An Na; Eom, Bang Wool; Kang, Beodeul; Kim, Bum Jun; Min, Byung-Hoon; Tae, Chung Hyun; Choi, Chang In; Lee, Choong-Kun; An, Ho Jung; Byun, Hwa Kyung; Im, Hyeon-Su; Kim, Hyung-Don; Cho, Jang Ho; Pak, Kyoungjune; Kim, Jae-Joon; Bae, Jae Seok; Yu, Jeong Il; Lee, Jeong Won; Choi, Jungyoon; Kim, Jwa Hoon; Choi, Miyoung; Jung, Mi Ran; Seo, Nieun; Eom, Sang Soo; Ahn, Soomin; Kim, Soo Jin; Lee, Sung Hak; Lim, Sung Hee; Kim, Tae-Han; Han, Hye Sook

Phase II Trial of Neoadjuvant Docetaxel/Cisplatin/5-Fluorouracil Combined with Pegteograstim for Unresectable, Locally Advanced Sinonasal Squamous Cell Carcinoma: KCSG HN18-07

新辅助多西他赛/顺铂/5-氟尿嘧啶联合培格司亭治疗不可切除的局部晚期鼻窦鳞状细胞癌的II期临床试验:KCSG HN18-07

Keam, Bhumsuk; An, Ho Jung; Shin, Seong Hoon; Kim, Min Kyoung; Cho, Jung Hae; Seo, Seyoung; Kim, Sung-Bae

A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial

尼达尼布治疗转移性或复发性头颈部鳞状细胞癌患者的II期试验:KCSG HN 15-16 TRIUMPH试验中尼达尼布组的深入分析

Kim, Kyoo Hyun; Lim, Sun Min; Ahn, Hee Kyung; Lee, Yun-Gyoo; Lee, Keun-Wook; Ahn, Myung-Ju; Keam, Bhumsuk; Kim, Hye Ryun; Lee, Hyun Woo; An, Ho Jung; Kim, Jin-Soo

Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design

精准肿瘤临床试验:基于生物标志物驱动的自适应设计的II期临床试验的系统评价

Ha, Hyerim; Lee, Hee Yeon; Kim, Jee Hyun; Kim, Do Yeun; An, Ho Jung; Bae, SeungJin; Park, Hye-Sung; Kang, Jin Hyoung

Common Cancer-Related Factors and the Risk of Developing Kaposi Sarcoma in Individuals without AIDS: Korea National Health Insurance Services Claims Database

常见癌症相关因素与非艾滋病患者罹患卡波西肉瘤的风险:韩国国民健康保险服务索赔数据库

Shin, Ji Eun; Han, Kyungdo; An, Ho Jung; Park, Hyung Soon; Shim, Byoung Yong; Kim, Hyunho

Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer

同步性不可切除转移性结直肠癌一线原发肿瘤切除术的临床结果

Shin, Ji Eun; An, Ho Jung; Shim, Byoung Yong; Kim, Hyunho; Park, Hyung Soon; Cho, Hyeon-Min; Kye, Bong-Hyeon; Yoo, Ri Na; Moon, Ji-Yeon; Kim, Sung Hwan; Lee, Jonghoon; Lee, Hyo Chun; Jung, Ji-Han; Lee, Kang-Moon; Lee, Ji Min

A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation

一项针对接受六个疗程 XELOX(卡培他滨联合奥沙利铂)治疗后未出现疾病进展的晚期胃腺癌患者的随机 III 期研究,随后进行卡培他滨维持治疗或临床观察。

Lee, Guk Jin; Kim, Hyunho; Cho, Sung Shim; Park, Hyung Soon; An, Ho Jung; Woo, In Sook; Byun, Jae Ho; Hong, Ji Hyung; Ko, Yoon Ho; Sun, Der Sheng; Won, Hye Sung; Jin, Jong Youl; Park, Ji Chan; Kim, In-Ho; Roh, Sang Young; Shim, Byoung Yong

Tumor-associated microbiome features of metastatic colorectal cancer and clinical implications

转移性结直肠癌的肿瘤相关微生物组特征及其临床意义

An, Ho Jung; Partha, Mira A; Lee, HoJoon; Lau, Billy T; Pavlichin, Dmitri S; Almeda, Alison; Hooker, Anna C; Shin, Giwon; Ji, Hanlee P

Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy

血浆肿瘤突变负荷与接受抗程序性死亡受体-1单药治疗的非小细胞肺癌患者的临床获益相关。

Lee, Jii Bum; Park, Hyung Soon; Choi, Su Jin; Heo, Seong Gu; An, Ho Jung; Kim, Hye Ryun; Hong, Min Hee; Lim, Sun Min; Chang, Kyle; Quinn, Katie; Odegaard, Justin; Shim, Byoung Yong; Cho, Byoung Chul